It’s Friday…which means it’s time for the Center for Health Innovation’s Weekly Health Roundup.
The U.S. presidential debate dominated media coverage this week, with healthcare taking a backseat to foreign policy, the economy, job creation, and other contentious topics Tuesday night. Nonetheless, you may have caught the candidates’ brief exchanges on women’s health issues, health insurance premiums, and Medicare in between the jabs and hooks.
In honor of World Food Day this week, and at the intersection of food and politics, did you savor Michael Pollan’s article on the political implications of the burgeoning food movement in the New York Times Magazine’s annual Food and Drink issue? Foodies and health-minded individuals will surely pay close mind to California this November as it votes on Proposition 37, requiring genetically modified foods to be appropriately identified and labeled. And speaking of labels, Mark Bittman’s exercise in reimagining a more useful and streamlined food label distills food worthiness down to a numerical score and a traffic light color-coded system. Is this an oversimplification or a step in the right direction?
Peeking ahead to next week, Adelphi relishes National Food Day on October 24 with a series of on-campus events to highlight the need for sustainable, affordable, and healthy food for all. Free events include the Long Island premiere of The Harvest/La Cosecha, the story of migrant child workers working on U.S. farms; a Farmers Market; Iron Chef Competition; and an interactive food memory project. To kick off National Food Day, famed celebrity chef and motivational speaker Chef LaLa brings her cooking show to Adelphi on Tuesday, October 23. Make sure to check out all of our Food Day-related events.
If an apple a day keeps the doctor away, it seems a vitamin may be a worthy substitute. Encouraging news for men who take daily multivitamins came from a paper presented at the American Association for Cancer Research conference. Men taking a daily multivitamin were diagnosed with 8% fewer cancers than their placebo counterparts.
